CYTOLYTIC EFFECTS OF COMPLEMENT CLEAVAGE PRODUCT, C3A

被引:35
|
作者
FERLUGA, J [1 ]
SCHORLEMMER, HU [1 ]
BAPTISTA, LC [1 ]
ALLISON, AC [1 ]
机构
[1] CLIN RES CTR,DIV CELL PATHOL,HARROW HA1 3UJ,MIDDLESEX,ENGLAND
关键词
D O I
10.1038/bjc.1976.223
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:626 / 634
页数:9
相关论文
共 50 条
  • [1] PRODUCTION OF COMPLEMENT CLEAVAGE PRODUCT, C3A, BY ACTIVATED MACROPHAGES AND ITS TUMOROLYTIC EFFECTS
    FERLUGA, J
    SCHORLEMMER, HU
    BAPTISTA, LC
    ALLISON, AC
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1978, 31 (03): : 512 - 517
  • [2] C3 complement cleavage fragments (C3A and DES-ARG C3A) - New unexpected regulators of megakaryopoiesis and thrombopoiesis
    Wysoczynski, M
    Reca, R
    Kucia, M
    Yan, J
    Ratajczak, J
    Ratajczak, MZ
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 64 - 64
  • [3] The Complement C3a and C3a Receptor Pathway in Kidney Diseases
    Gao, Shuang
    Cui, Zhao
    Zhao, Ming-hui
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [4] MACROPHAGE SECRETION AND COMPLEMENT CLEAVAGE PRODUCT C3A IN PATHOGENESIS OF INFECTIONS BY MYCOPLASMAS AND L-FORMS OF BACTERIA AND IN IMMUNITY TO THESE ORGANISMS
    TAYLORROBINSON, D
    SCHORLEMMER, HU
    FURR, PM
    ALLISON, AC
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1978, 33 (03): : 486 - 494
  • [5] CONTROL OF HUMAN CLASSICAL COMPLEMENT PATHWAY C-3 CONVERTASE - INHIBITION OF C-3 CLEAVAGE BY C3A
    STRUNK, RC
    WEBSTER, RO
    MOLECULAR IMMUNOLOGY, 1982, 19 (11) : 1404 - 1404
  • [6] LEVELS OF COMPLEMENT FACTOR-C3 AND ITS ACTIVATED PRODUCT, C3A, IN OPERATIVELY SALVAGED BLOOD
    SIEUNARINE, K
    WETHERALL, J
    LAWRENCEBROWN, MMD
    GOODMAN, MA
    PRENDERGAST, FJ
    HELLINGS, M
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1991, 61 (04): : 302 - 305
  • [7] The Role of Complement C3a Receptor in Stroke
    Ahmad, Saif
    Bhatia, Kanchan
    Kindelin, Adam
    Ducruet, Andrew F.
    NEUROMOLECULAR MEDICINE, 2019, 21 (04) : 467 - 473
  • [8] The Role of Complement C3a Receptor in Stroke
    Saif Ahmad
    Kanchan Bhatia
    Adam Kindelin
    Andrew F. Ducruet
    NeuroMolecular Medicine, 2019, 21 : 467 - 473
  • [9] C3a complement split product: possible biomarker of disease activity in patients with neuromyelitis optica
    Nytrova, P.
    Trendelenburg, M.
    Kemlink, D.
    Horakova, D.
    Pavlina, Z.
    Waters, P.
    Volna, J.
    Vincent, A.
    Havrdova, E.
    Potlukova, E.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 539 - 540
  • [10] Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth
    Coulthard, Liam G.
    Woodruff, Trent M.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (08): : 3542 - 3548